Your Child's Diagnostic Workup and Lab Reports
At a Glance
Specialists evaluate ITK deficiency by combining genetic testing with immune-cell counts and T-cell function tests. Biallelic ITK variants, low CD4 or iNKT cells, impaired signaling, antibody abnormalities, and EBV viral load help clarify the child's immune problem.
Navigating your child’s lab reports can feel like learning a new language. However, understanding these numbers is one of the most effective ways to advocate for their care. Doctors use a combination of genetic testing, cell counting (flow cytometry), and T-cell activity tests (functional assays) to confirm a diagnosis of ITK deficiency [1][2].
Decoding the Genetic Report
The diagnostic confirmation of ITK deficiency comes from looking at the DNA instructions for the ITK gene. This is typically done through a targeted gene panel (testing specific known genes) or Whole Exome Sequencing (WES), which looks at all the protein-coding parts of the DNA [3][4].
When you look at the genetic report, you may see the term biallelic pathogenic variants. This simply means that both copies of the ITK gene—one from each parent—have mutations that prevent them from working correctly [5][6].
- Homozygous: The mutations on both genes are identical.
- Compound Heterozygous: The two mutations are different from each other, but both still break the gene [6][4].
Note: Variant classification requires expert interpretation, as “Variants of Uncertain Significance” (VUS) do not establish a diagnosis alone.
Flow Cytometry: Counting the Defense Force
Flow cytometry is a specialized blood test that sorts and counts different types of immune cells. In ITK deficiency, several cell types often show characteristic patterns:
- CD4+ T-cell Lymphopenia: Most children with this condition have a low number of “Helper” T cells (CD4 cells) for their age [7][8].
- Missing iNKT Cells: Invariant Natural Killer T (iNKT) cells are often nearly absent. These “scout” cells are crucial for the early detection of viruses like EBV [8][9].
- Double-Negative (DN) T Cells: You may see an expansion of “double-negative” T cells—cells that lack both the CD4 and CD8 markers. This is a common finding when the normal T-cell development process is disrupted [7].
- Low NK Cells and Tregs: Some children also show low levels of Natural Killer (NK) cells and Regulatory T cells (Tregs), which help keep the immune system balanced [8][4].
Functional Assays: Testing the “Work” of Cells
Because sometimes a cell is present but doesn’t work, doctors perform functional assays. These tests take your child’s T cells in a lab and “stimulate” them to see if they respond properly.
- Proliferation Assays (CD3/CD28): Scientists use chemicals to signal the T cells to multiply. In ITK deficiency, the cells often fail to multiply (proliferate) as they should [3][7].
- Phosphorylation (Signaling) Tests: This test looks at whether the “volume dial” (the signaling proteins like ITK and PLC-gamma-1) actually turns on when the cell is triggered. Reduced “phospho-signaling” is a hallmark of this genetic defect [8].
- Cytokine Production: The lab may measure how much Interferon-gamma (IFN-gamma) or other immune chemicals the cells produce. Children with complete ITK deficiency often produce much lower levels of these chemicals when fighting threats like the bacteria that cause tuberculosis [7].
Monitoring Antibodies and EBV
Your child’s reports will also track quantitative immunoglobulins (IgG, IgA, and IgM). Many children have dysgammaglobulinemia, where these antibody levels are too low or imbalanced, making them more vulnerable to common infections [2][3].
Additionally, the lab will perform regular EBV PCR tests to measure the “viral load” (how much Epstein-Barr Virus is in the blood). While a rising viral load can be a warning sign, doctors look at this number alongside physical symptoms—like an enlarged spleen—to decide if treatment is needed [10][11].
A Discussion Aid for Your Specialist Visits
Use this list as a discussion aid (not a mandatory checklist, as these are specialized tests) during your clinic visits to understand which tests your expert team feels are necessary:
- [ ] Genetic Confirmation: Identification of biallelic ITK mutations.
- [ ] Full Lymphocyte Subset Panel: Absolute counts of CD3, CD4, CD8, B cells, and NK cells compared to age-specific reference ranges.
- [ ] Advanced Phenotyping: Presence/absence of iNKT cells and double-negative (DN) T cells.
- [ ] T-cell Proliferation: Results of CD3/CD28 stimulation tests.
- [ ] Quantitative Immunoglobulins: Baseline levels of IgG, IgA, IgM, and IgE.
- [ ] EBV Status: Baseline EBV PCR (viral load).
- [ ] TCR Signaling: If available, specialized testing for ITK or PLC-gamma-1 phosphorylation.
Common questions in this guide
How is ITK deficiency diagnosed in a child?
What does a biallelic ITK variant mean on a genetic report?
What can flow cytometry show in ITK deficiency?
Why are T-cell functional assays needed?
What does EBV PCR monitoring tell us?
One line in your results can change your plan.
A rising EBV viral load can be a warning sign, but whether treatment is needed is decided alongside physical symptoms, such as an enlarged spleen. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Combined immunodeficiency due to ITK deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations.
Shadur B, Abuzaitoun O, NaserEddin A, et al.
Clinical immunology (Orlando, Fla.) 2019; (198()):39-45 doi:10.1016/j.clim.2018.12.016.
PMID: 30572125 - 2
Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?
Ghosh S, Drexler I, Bhatia S, et al.
Frontiers in immunology 2018; (9()):979 doi:10.3389/fimmu.2018.00979.
PMID: 29867957 - 3
Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells.
Eken A, Cansever M, Somekh I, et al.
Journal of clinical immunology 2019; (39(4)):391-400 doi:10.1007/s10875-019-00632-5.
PMID: 31025232 - 4
From T-cell defect to tumorigenesis: Epstein-Barr virus-associated smooth muscle tumors in ITK deficiency.
Oussama K, Idrissi Fawzi F, Benhsaien I, et al.
Clinical and experimental immunology 2026; (220(1)) doi:10.1093/cei/uxag028.
PMID: 42132280 - 5
Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.
Lechner KS, Neurath MF, Weigmann B
Journal of molecular medicine (Berlin, Germany) 2020; (98(10)):1385-1395 doi:10.1007/s00109-020-01958-z.
PMID: 32808093 - 6
Multiple Tumors in a Patient with Interleukin-2-Inducible T-Cell Kinase Deficiency: A Case Report.
Di Filippo M, Tallone R, Muraca M, et al.
International journal of molecular sciences 2024; (25(23)) doi:10.3390/ijms252313181.
PMID: 39684891 - 7
Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis.
Ogishi M, Yang R, Rodriguez R, et al.
The Journal of experimental medicine 2023; (220(1)) doi:10.1084/jem.20220484.
PMID: 36326697 - 8
Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase.
Howe MK, Dowdell K, Roy A, et al.
Frontiers in immunology 2019; (10()):2000 doi:10.3389/fimmu.2019.02000.
PMID: 31507602 - 9
Allele-sensitive mutant, Itkas, reveals that Itk kinase activity is required for Th1, Th2, Th17, and iNKT-cell cytokine production.
Kannan A, Lee Y, Qi Q, et al.
European journal of immunology 2015; (45(8)):2276-85 doi:10.1002/eji.201445087.
PMID: 25989458 - 10
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.
Marzolini MAV, Wilson AJ, Sanchez E, et al.
Transplantation and cellular therapy 2021; (27(8)):682.e1-682.e12 doi:10.1016/j.jtct.2021.04.020.
PMID: 33962069 - 11
Epstein-Barr Virus-Associated Smooth Muscle Tumors in inborn Errors of Immunity: A single-center Case Series and Literature Overview.
Aliyeva G, Bajin IY, Orhan D, et al.
Journal of clinical immunology 2025; (45(1)):144.
PMID: 41099879
This page is for informational purposes only and does not constitute medical advice. Your child's pediatric immunology and genetics team should interpret genetic, immune-cell, and EBV results in the context of their complete clinical evaluation.